2. Academic Validation
  3. PTK6 drives HNRNPH1 phase separation to activate autophagy and suppress apoptosis in colorectal cancer

PTK6 drives HNRNPH1 phase separation to activate autophagy and suppress apoptosis in colorectal cancer

  • Autophagy. 2025 Mar 24:1-20. doi: 10.1080/15548627.2025.2481001.
Bingyuan Chen 1 2 3 4,  Bowen Liu 1 3 4,  Junnan Chen 3 4,  Wenjing Li 5,  Ning Ma 3 4,  Jianquan Liu 3 4,  Ruizhi Fan 1 2,  Qihang Hu 3 4,  Hu Song 1 2,  Yixin Xu 1 2,  Tao Jiang 1 2,  Jun Song 1 2
Affiliations

Affiliations

  • 1 Department of General Surgery, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
  • 2 Institute of Digestive Diseases, Xuzhou Medical University, Xuzhou, Jiangsu, China.
  • 3 Affiliated First Clinical College, Xuzhou Medical University, Xuzhou, Jiangsu, China.
  • 4 Central Laboratory, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
  • 5 Central Laboratory, Xuzhou NO.1 people's hospital, Xuzhou, Jiangsu, China.
PMID: 40103198 DOI: 10.1080/15548627.2025.2481001
Abstract

Macroautophagy/Autophagy is the principal mechanism that mediates the delivery of various cellular cargoes to lysosomes for degradation and recycling, and has been reported to play a crucial role in colorectal Cancer (CRC) pathogenesis and progression. Targeting Autophagy may be a promising therapeutic strategy for CRC. However, the specific functions and potential mechanisms of Autophagy in CRC remain unclear. In the present study, we discovered that PTK6 (protein tyrosine kinase 6) could activate Autophagy and inhibit CRC Apoptosis. PTK6 physically interacted with HNRNPH1 and mediated tyrosine phosphorylation at Y210 of HNRNPH1, which promoted the latter's liquid-liquid phase separation (LLPS). Furthermore, LLPS of HNRNPH1 formed biomolecular condensates and triggered splicing-switching of the NBR1 exon 10 inclusion transcript, thereby activating Autophagy and suppressing Apoptosis of CRC. Additionally, PDO and CDX models indicated that tilfrinib, an inhibitor targeting PTK6, could inhibit CRC growth. Overall, our findings reveal the novel PTK6-HNRNPH1-NBR1 regulatory Autophagy axis and provide a potential therapy target for CRC.Abbreviation: 1,6HD: 1,6-hexanediol, CQ: chloroquine, CRC: colorectal Cancer, DFS: disease-free survival, FRAP: fluorescence recovery afterphotobleaching, GSEA: Gene Set Enrichment Analysis, GTEx: Genotype-Tissue Expression, HNRNPH1: heterogeneous nuclearribonucleoprotein H1, IDRs: intrinsically disordered regions, IHC: immunohistochemical, KEGG: Kyoto Encyclopedia of Genes and Genomes,LLPS: liquid-liquid phase separation, NBR1: NBR1 Autophagy cargoreceptor, OS: overall survival, PDO: patient-derivedorganoid, PTK6: protein tyrosine kinase 6, PTMs: post-translationalmodifications, SE: skipped exon, TCGA: The Cancer Genome Atlas, TEM: transmission electron microscopy, TMA: tissue microarray, TyrKc: tyrosine kinase catalytic.

Keywords

Alternative splicing; LLPS; PTK6; autophagy; colorectal cancer.

Figures
Products
Inhibitors & Agonists
Other Products